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Preface | 3
Demographic ageing is a key societal and 
economic challenge in Europe. Support-
ing active and healthy ageing is important 
to ensure individuals continue contributing 
to society as they grow older, improve the 
quality of life of older citizens and to reduce 
unsustainable pressure on health systems.1 
The European Commission has launched 
the European Innovation Partnership on 
Active and Healthy Ageing (the Partnership) 
to tackle the challenge of an ageing popula-
tion (COM (2012) 83 final). It sets an impor-
tant target of increasing the healthy lifespan 
of EU citizens by 2 years by 2020.
The Joint Research Centre (JRC), as the Euro-
pean Commission’s in-house science ser-
vice, has started activities in the areas of nu-
trition, ageing and public health. As a first 
1. http://ec.europa.eu/health/ageing/docs/com_2012_83_en.pdf.
step to support the aims of the Partnership, 
the JRC investigates the role of nutrition to 
promote active and healthy ageing and to 
raise awareness of its contribution. The pre-
sent report highlights the challenges older 
people face including undernutrition and 
functional decline. It reviews the current ev-
idence on key nutrient intakes and the pre-
vention and treatment of age-related condi-
tions, particularly the role of micronutrient 
supplements. During this report, a number 
of research gaps are identified and several ar-
eas for future research are highlighted. It is 
our hope that this report will raise awareness 
of nutrition as a key contributor to healthy 
ageing, and that more attention will be giv-
en to diet and nutrition in policymaking to 
protect our older citizens.
Preface
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Europe is facing an ageing population. Life 
expectancy is at its highest and many Euro-
pean populations are experiencing major 
demographic changes and transition to-
wards a much older population structure. 
However, despite living longer, many peo-
ple suffer ill-health or disability in the last 15 
to 20 years of life. To encourage active and 
healthy ageing and to help increase healthy 
life expectancy, the European Commission 
has launched the European Innovation Part-
nership on Active and Healthy Ageing (the 
Partnership), which aims to add an average 
of two healthy life years in Europe by 2020.
This report aims to support the Partnership 
and to review the contribution of diet and 
nutrition in increasing healthy life years 
and promoting active and healthy ageing 
(AHA). The report gives a description of the 
main determinants of AHA including eco-
nomic, social and behavioural factors and 
how they may relate to diet. It focusses on 
the issue of undernutrition in older people– 
both a cause and consequence of functional 
decline. Given the importance of undernu-
trition and that micronutrient deficiency 
is a common problem in older adults, this 
report summarises the evidence regarding 
micronutrient supplementations in the pre-
vention and treatment of age-related diseas-
es and conditions. At this stage, the current 
evidence seems insufficient to support the 
use of vitamin and mineral supplementa-
tion to prevent or treat specific cognitive or 
 
 
 
 
functional impairments in older people, al-
though it does not imply that supplements are 
not effective. As it stands, another approach 
to ensure proper nutrition in older people is 
to maximise their intake of essential vitamins 
and minerals from natural food sources. In-
deed, evidence so far on the Mediterranean 
Diet as a whole diet approach to promote 
health, increase longevity and reduce the risks 
of various age-related diseases supports this in 
a number of observational studies.
A number of research gaps are also high-
lighted in this report, including:
1) Further research on the wider determi-
nants of AHA, e.g. social, economic and 
environmental aspects and their interrela-
tionships with dietary behaviours in older 
people.
2) To identify the most effective strategies 
to promote public health messages to the 
older population.
3) Further evidence on life-course approach 
to ageing.
4) To develop a set of validated, agreeable, 
cost-effective and non-invasive measures 
and tools to quantify AHA outcomes, 
including the quality of diet, fitness and 
well-being in older people.
5) Above all, there is a need to provide bet-
ter guidance on diet and nutrition for old-
er people and a set of age-specific, up-to-
date dietary recommendations is essential 
to achieve AHA.
Executive summary
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AD     Alzheimer’s disease 
AHA    active and healthy ageing
AMD    age-related macular degeneration
BMR    basal metabolic rate 
CR     calorie restriction
CVD     cardiovascular disease
E%     percentage of daily energy 
EAAs    essential amino acids 
EC     European Commission 
EFSA    European Food Safety Authority 
EIP on AHA European Innovation Partnership on Active and Healthy Ageing
EPIC    European Prospective Investigation into Cancer and Nutrition
EU     European Union
HALE    The Healthy Ageing: a Longitudinal study in Europe
GI     gastro-intestinal 
LDL    low-density lipoprotein 
MCI    mild cognitive impairment 
MD     Mediterranean Diet 
MUFA   monounsaturated fatty acids 
n-3     omega-3 fatty acids
PAL     physical activity level 
PUFA    polyunsaturated fatty acids 
RCT    randomised controlled trial
TEE     total energy expenditure 
TFA     trans fatty acids
WHO    World Health Organisation
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Figure 1.1. Population pyramids in EU-27, comparison between 2011 data and projection in 2060. X-axis: percentage of the 
total population. Source: Eurostat [3]
Figure 1.2. Population structure by major age groups in EU-27, comparison between 2011 and projections in 2020-2060. 
Y-axis: percentage of the total population. Source: Eurostat [3]
1.1. Europe’s ageing population
The European Union (EU) is facing an age-
ing population for reasons including con-
tinual rise of life expectancy and relatively 
low birth rates [1]. The current EU popula-
tion structure is characterised by a large pro-
portion of post-war baby-boomers, i.e. those 
born between mid-late 1940s and the late 
1960s [2]. However, part of this generation 
have now entered retirement and the rest 
will soon follow, which means that Europe 
will go through major demographic changes 
and transition towards a much older popu-
lation structure in the future (Figure 1.1). The 
population of Europeans aged 65 years and 
older is projected to increase from 17.4% to 
nearly 30% by 2060 (Figure 1.2) [2] while the 
population of those aged 80 years and older 
is predicted to triple during this period [3].
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e
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
45 3 2 1 0 1 2 3 4 5
Solid colour: 2060 • Bondered: 2011Men Women
0
100
75
50
25
2011 2020 2030 2040 2050 2060
4.8 5.8 7.0 8.9 11.0 12.0
12.7 14.4 16.6 18.0 17.6 17.5
66.9 64.3 61.7 59.0 57.0 56.2
15.6 15.5 14.7 14.2 14.3 14.2
80+ years
65-79 years
15-64 years
0-14 years
1. Overview
8 | The Role of Nutrition in Active and Healthy Ageing
1.2. Healthy life years
While it may seem that living longer is a 
good thing–and indeed the advances of 
modern technologies, medicine and health-
care have enabled us to do so, the not-so-
good news is that there is a gap between life 
expectancy 2 and healthy life years 3 in the EU [1]. 
For example, in 2009, mean life expectancy 
at birth in the EU-27 was 76.7y for men and 
82.6y for women, but healthy life years were 
61.6y and 62.5y, respectively [1]. This means, 
although people who were born in the year 
2009 are expected to live well into their sev-
enties and eighties, they are likely to be in 
ill-health and/or with disability in the last 
15 to 20 years of life. Furthermore, if life ex-
pectancy continues to rise as predicted and 
healthy life years do not increase at the same 
rate, the time spent in ill health will be even 
longer in the future.
Spending more years in ill health and dis-
ability not only affects the quality of life of 
individuals and their families, but also puts 
pressure on public health and care services, 
consequentially leading to substantial social 
and economic impact on the society. There-
fore, it is crucial to identify appropriate strat-
2. ‘Life expectancy’ at a certain age is the mean additional num-
ber of years that a person of that age can expect to live, if subjected 
throughout the rest of his or her life to the current mortality con-
ditions. ‘Life expectancy at birth’ is the number of years a person 
is expected to live at birth. http://epp.eurostat.ec.europa.eu/statis-
tics_explained/index.php/Glossary:Life_expectancy.
3. ‘Healthy life years’ also known as disability-free life expec-
tancy, is defined as the number of years that a person is expected 
to continue to live in a healthy condition. http://epp.eurostat.
ec.europa.eu/statistics_explained/index.php/Glossary:Healthy_
life_years_(HLY).
egies to help the population age healthier. 
Concerted, multi-level efforts will undoubt-
edly be needed, from the responsibility of 
self-care of the individuals, to coordinated 
care and health services at the community 
level and to reformed policies on health-
care, workforce and pension arrangements at 
the national level [1]. From the individual’s 
standpoint, the utmost valuable investment 
one can make is in one’s health. Appropriate 
lifestyle behaviours including good nutri-
tion and physical activity throughout life are 
the first steps in preventing chronic diseases 
and disabilities in old age and to increase 
healthy life years. Subsequently with good 
health, older people can continue to be ac-
tive in their community, thus having a posi-
tive knock-on effect on the society.
1.3. EU response to ageing challenges
Recognising the importance of the above 
developments, the European Commission 
has identified active and healthy ageing as 
a major societal challenge common to all 
European countries, and an area which pre-
sents considerable potential for Europe to 
lead the world in providing innovative re-
sponses to this challenge. In 2011 the Euro-
pean Commission launched the pilot Euro-
pean Innovation Partnership on Active and 
Healthy Ageing (hereafter referred to as EIP 
on AHA or the Partnership), which aims to 
add an average of two healthy life years in 
Europe by 2020 [4] while pursuing a triple 
win4 for Europe.
4. Triple win refers to 1) improving the health status and quality 
of life of European citizens, with particular focus on older people; 
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The Partnership aims to achieve this by 
bringing together key stakeholders from a 
variety of backgrounds, which share a com-
mon vision and commit to take priority 
actions to address the challenge of ageing 
through innovation. More specifically, a 
number of interventions undertaken by EIP 
on AHA stakeholders to improve preven-
tion as well as care & cure include measures 
targeted at nutrition (and undernutrition). 
Further information on the EIP on AHA is 
attached in the Annex, which includes exam-
ples of nutrition activities within the Part-
nership.
1.4. Aim of report and chapters overview
The aim of this report is to critically exam-
ine the contribution of diet and nutrition 
in active and healthy ageing (AHA) and to 
highlight its importance in the ageing pro-
cess. Although it is still an early stage in re-
search to appropriately quantify the exact 
 
2) supporting the long-term sustainability and efficiency of health 
and social care systems; and 3) enhancing the competitiveness of 
EU industry.
contribution diet has on increasing healthy 
life years, we believe it is time to set the 
ground for gathering evidence base in age-
ing and raise awareness for further research 
directions in this very important age group. 
The current report gives a brief description 
of the key determinants of AHA including 
economic, social and behavioural contribu-
tions and their relationship to diet (Chapter 
2). Secondly, it describes the issue of under-
nutrition in older people and the functional 
changes that lead to poor food and nutrient 
intake (Chapter 3). Based on current scien-
tific evidence, the report summarises how 
specific nutrients and whole diet approach 
may promote various aspects of AHA, in-
cluding reducing and delaying physical and 
cognitive declines commonly seen in older 
people (Chapter 4). The last part of the re-
port (Chapter 5) concludes our findings and 
highlights future research opportunities in 
nutrition and AHA.
10 | The Role of Nutrition in Active and Healthy Ageing
Active and healthy ageing is ‘the process of 
optimizing opportunities for health, partici-
pation and security in order to enhance qual-
ity of life as people age. It applies to both in-
dividuals and population groups’ ([4], p. 5). 
‘Health’ refers to ‘physical, mental and social 
well-being’ ([4], p. 5). ‘Active’ refers to ‘con-
tinuing participation in social, economic, 
cultural, spiritual and civic affairs, as well 
as the ability to be physically active or to 
participate in the labour force’ ([4], p. 5). To 
embrace the notion of ‘active and healthy 
ageing’, it is important to adopt health-en-
hancing lifestyles that include healthy eating 
and adequate exercise [5].
Figure 2. 1. Determinants of active and healthy ageing. 
Source: European Commission [4]
In the Strategic Implementation Plan of the 
EIP on AHA [4], the European Commission 
summarised the six important determinants 
of AHA (Figure 2.1) based on the WHO’s pol-
icy framework on active ageing [6]. Such key 
factors and the interplay between them will 
predict how well people age. The following 
sections describe these six determinants and 
where appropriate, their relationships with 
food and dietary behaviour are mentioned.
2.1. Economic determinants
The WHO active ageing policy framework 
identified three important economic factors 
that have particular importance for ageing: in-
come, work and social protection [6]. People 
with low income are at higher risk of ill health 
and disabilities, as healthy foods, health care 
and housing are less affordable and accessible 
to them than to their wealthier counterparts. 
The type of work people engage in not only 
affects their level of income but also their 
overall well-being. Being active and produc-
tive in work and voluntary activities, and to 
be recognised for such valuable contributions 
will have beneficial effects on the individual 
psychosocial well-being. In many countries, 
social protection and insurance programmes 
exist to provide financial aid to older people 
who are no longer able to work. In recent 
years, policy reforms have favoured the com-
bination of state and private support for old 
age security that encourages people to work 
for longer and adopt gradual retirement [6].
2. Determinants of active and healthy ageing
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2.2. Health and social service systems
Having access to quality health and social 
services is crucial for AHA. Good health sys-
tems should ‘take a life course perspective 
that focuses on health promotion, disease 
prevention and equitable access to quality 
primary health care and long-term care’ ([6], 
p. 21). Health promotion and disease pre-
vention are particularly important, as the 
potential cost savings from avoiding treat-
ment on diseases (especially chronic, non-
communicable diseases) and injuries can 
be high. Vaccination against influenza and 
pneumococcal infections as well as regular 
screening for malnutrition and frailty are ef-
fective strategies to prevent certain diseases 
and reduce mortality among older people, 
particularly those with underlying medical 
conditions. It has been estimated that influ-
enza vaccination can reduce severe illnesses 
by up to 60% and influenza-related deaths 
by up to 80% [7]. Given the increasing inci-
dence of chronic diseases, primary care and 
long-term care systems (including home 
care, rehabilitation, and palliative care) must 
be equipped to meet the needs from the rap-
idly expanding ageing populations [6].
2.3. Physical environment
To ensure older adults can remain active, in-
dependent and engaged with their commu-
nities, their physical environment (i.e. neigh-
bourhood and surroundings) needs to be in 
good and safe condition for them to carry 
out their day-to-day activities. The WHO 
introduced the concept of the age-friendly 
city, to encourage cities, communities and 
neighbourhoods to adapt their structures 
and services to be accessible to older people 
with varying needs and capacities [8]. Acces-
sible and affordable public transportation 
systems are important to allow older people 
to stay mobile in their communities for ac-
tivities such as food shopping, dining-out or 
other social engagements. After retirement, 
people may have more time to enjoy out-
door activities as well as various community 
facilities [9]. Features such as a pleasant and 
clean environment; ample green spaces and 
walkways; the availability of outdoor seating 
to rest; and the adequacy of smooth, level, 
non-slip surfaces and well-lit pavements are 
important to motivate people to stay physi-
cally active and independent into old age 
[8]. Safe and affordable housing and care 
homes, as well as households free of hazards 
are also critical to the physical health and 
well-being of older adults [6].
2.4. Social environment
The level of social support and degree of 
social interaction older people have can 
greatly affect their health and well-being. 
Studies have shown that social isolation can 
influence older people’s eating habits and 
behaviour. Those who live alone eat fewer 
meals per day, have lower daily intake of 
protein, fruits and vegetables, experience a 
loss of appetite and tend to be thinner than 
those living with family [10]. Isolation and 
the lack of social support are also associated 
with increased risk of chronic diseases and 
mortality [11].
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Low education and literacy level are be-
lieved to indirectly relate to disability and 
early death. It has been suggested that edu-
cation in early life and lifelong learning can 
help people to stay independent, confident 
and skilled as they age [6]. Keeping up with 
modern technologies such as electronic 
communications can also help to promote 
social support and social interactions with 
younger people, and to bridge the gaps be-
tween generations [6].
2.5. Cultural and personal determinants
Cultural values, norms and traditions shape 
the way people age as they affect other age-
ing determinants [6]. For instance, in some 
cultures it may be the norm to have extended 
families or different generations living in 
one household, where the grandparents are 
cared for by family members [6]. In other 
societies, older people may have to rely on 
community care services to sustain daily life.
Personal 5 factors are also key determinants 
of how well a person ages over the lifetime. 
Gender differences in life expectancy are 
well known across both developed and de-
veloping countries (e.g. women tend to live 
longer). The underlying cause for this differ-
ence is not clear but is likely due to a combi-
nation of genetic variation, immune system 
responses, hormones, disease patterns and 
risk behaviours between men and women 
[12]. In terms of the genetic influence on hu-
man lifespan, family studies on twins have 
5. Personal factors in this context refer to biological and genetic 
factors.
demonstrated very moderate effects (20 -30% 
variation) on longevity accounted for by 
hereditary factors [13] [14] [15]. Interesting-
ly, studies on older twins (aged 60y+) have 
shown that genetic influences on lifespan 
tend to be minimal prior to age 60y but 
will increase thereafter [13]. For adults below 
age 60y, it appears that other external and 
environmental influences such as lifestyle 
behaviours will have a greater impact on 
how well they age rather than heredity [6]. 
Furthermore, recent research has suggested 
epigenetic factors such as DNA methylation 
[16], may influence the ageing process.
The rate of telomere 6 shortening is one of 
the biomarkers of biological ageing [17]. 
Studies in recent decades have found that 
telomeres shorten with advancing age and 
shorter telomeres are associated with various 
disease states including cancer and cardio-
vascular disease (CVD) [18]. Furthermore, 
recent studies have shown associations be-
tween shorter telomere length and other ac-
quired states such as smoking, obesity and 
emotional stress; while conversely, longer 
relative telomeres are seen in people who eat 
a healthier diet and exercise frequently [19]. 
2.6. Behavioural determinants
As mentioned, adopting positive lifestyle 
behaviours throughout the life course is one 
of the major determinants to achieve active 
and healthy ageing. Eating a well-balanced 
diet, engaging in physical activity, not smok-
6. Telomeres are found at the ends of chromosomes to protect 
them from damage, and they shorten during cell division [19].
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ing, moderate alcohol consumption and ap-
propriate use of medications are behaviours 
that can prevent or delay the onset of chronic 
disease, functional and mental decline as 
well as increase quality of life [6].
Smoking is a major cause of premature death 
and disability in Europe [1]. It increases the 
risk of lung cancer and reduces lung func-
tion, bone density and muscle strength in 
older people [6]. Studies have shown that be-
ing a current non-smoker (e.g. never smoked 
or have quit for a minimum of 15 years) was 
associated with healthier ageing [20].
Excessive alcohol consumption (e.g. repeat-
ed heavy drinking, more than five alcohol 
units 7 at a time, with the purpose of getting 
drunk [21]) is another problem in some older 
people [22]. It is directly linked to disorders 
such as malnutrition, causes damage to the 
liver, stomach and pancreas as well interact-
ing with prescription drugs. Furthermore, it 
increases the chances of falls and injuries [1] 
[6]. The evidence on the benefits of moder-
ate drinking on healthy ageing is currently 
not clear. In a review, one study demon-
strated that light or moderate alcohol con-
sumers were twice as likely to age healthily 
7. One unit of alcohol is 10ml of pure alcohol.
compared to those who did not drink at all, 
but other studies did not find similar results 
[20]. Another review on alcohol and Alzhei-
mer’s disease found no consensus regarding 
its impact, where seven studies suggested 
drinking alcohol decreased the risk of the 
disease, three studies found increased risk 
and nine others reported no effects between 
alcohol and Alzheimer’s disease [23].
Physical activity and healthy eating are 
known behaviours to add extensive health 
benefits to the ageing process. For physical 
activity, the WHO recommends older adults 
engage in at least 150 minutes of moderate-
intensity or 75 minutes of vigorous-intensity 
aerobic exercise per week [24]. Older adults 
who engage in regular exercise and activ-
ity have lower rates of all-cause mortality, 
chronic diseases (e.g. coronary heart disease, 
high blood pressure, stroke, type 2 diabetes, 
colon cancer and breast cancer), a higher 
level of cardiorespiratory and muscular fit-
ness, healthier body mass and composition, 
higher levels of functional health, better 
bone health, a lower risk of falling, as well as 
better cognitive function [24] [25]. The im-
portance of specific nutrients on AHA will 
be discussed in greater detail in Chapter 4.
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In the EU, over 20 million older people are 
at risk of undernutrition.8 This condition, 
along with associated health complications, 
are costing European health and social care 
systems around EUR 120 billion per year [4]. 
Undernutrition is a common disorder in old-
er people as a result of reduced nutrient intake 
and/or impaired metabolism [26], and it is 
associated with a number of age-related com-
plications, diseases and mortality in devel-
oped countries [4] [26]. Functional changes 
with ageing can greatly impact food intake 
and the degree of undernutrition in older 
people. Gradual decline of physical capabili-
ties, such as movement and mobility; chang-
es in physiological (particularly neurological) 
functions in the ageing body; chronic dis-
eases and other age-related illnesses can lead 
to changes in food choice, eating habits and 
dietary intake, subsequently increasing the 
risk of malnutrition. As well as being a cause 
of undernutrition, it is clear that functional 
decline and comorbidity are also the conse-
quence of chronic undernutrition, whereby 
long-term nutrient deficiencies can further 
aggravate these age-related conditions.
The following sections explore how func-
tional changes in areas including mobility, 
sensory, eye health, oral and gastro-intestinal 
health, cognitive function, as well as disease 
8. Undernutrition is one of the two types of malnutrition. The 
other type being overnutrition–which is the overconsumption of 
nutrients (in particular energy), that can lead to adverse health 
outcomes.
 
status are associated with dietary intake in 
older people that determine their risk of un-
dernutrition.
3.1. Mobility
Reduced mobility is a common concern in 
older people. Mobility refers to a person’s 
ability to move oneself independently and 
safely from one place to another [27]. It can 
be affected by the progression of chronic 
conditions such as obesity, physical inju-
ries such as fractures from falling, as well as 
physiological changes over time–predomi-
nantly in the musculoskeletal, neurologi-
cal and cardiorespiratory systems, leading 
to limited movement [27]. Sarcopenia is 
a complex multifactorial condition com-
mon in older adults that features the loss 
of muscle mass and strength, and it plays a 
major role in the pathogenesis of frailty and 
functional impairment [28]. After its peak in 
early-mid adulthood, skeletal muscle mass 
declines at the rate of 0.5 to 1.0% per year 
[29]. It affects 30% of adults over aged 60y 
and more than 50% of those aged 80y and 
older [29]. Other musculoskeletal disorders 
including osteoarthritis, rheumatoid arthri-
tis and osteoporosis are major causes of pain 
and functional limitations in the bones and 
joints in older people, particularly among 
women [30]. Limitations in movement and 
mobility are likely to affect accessibility of 
food, e.g. food shopping, meal preparation 
and subsequently food consumption.
3. Undernutrition and functional decline in ageing
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3.2. Sensory changes
Sense of smell and taste decline with age. 
Olfactory functions (sense of smell) dete-
riorate due to the progressive reduction of 
olfactory receptors and fibres in the olfac-
tory bulbs, as well as increased occurrences 
of receptor cell death [31]. Over time, the 
physiology of the taste cell membranes also 
changes and the functions of receptors and 
ion channels are affected [31]. The use of 
medications can also impact taste sensitiv-
ity [32] and it is known that zinc deficiency 
can affect taste acuity [33]. When senses are 
hampered, it may be harder to detect and 
recognise particular tastes and flavours, e.g. 
salt and sugar [31]; the eating experience be-
comes less enjoyable and the sense of thirst 
is less acute. The motivation to eat and the 
interest in food also decline. Subsequently, 
these sensory changes can affect older peo-
ple’s dietary habits such as adding extra salt 
and sugar to food and beverages to enhance 
flavour, as well as altering the quantity, qual-
ity and variety of food they consume [34], 
thus increasing their risk of undernutrition 
and the development of chronic conditions 
such as type 2 diabetes and hypertension.
3.3. Eyesight
The prevalence of eye diseases such as cata-
ract, diabetic retinopathy, glaucoma and 
age-related macular degeneration (AMD) 
are higher in old age [35]. In the United 
Kingdom, AMD causes blindness in 42% of 
people aged 65y to 74y, almost two-thirds 
of those aged 75y to 84y, and almost 75% of 
people aged 85y or older [36]. Poor vision in 
old people impacts their overall quality of 
life, as they are less independent to take care 
of their daily needs such as food shopping 
and meal preparation.
3.4. Oral health
Oral health is an important determinant of 
food consumption. With ageing, the physi-
ology of the oral cavity changes and older 
adults often experience issues such as the 
loss of teeth, reduced saliva secretion and 
flow (dry mouth) and a reduction in muscle 
and connective tissue elasticity in the oral 
cavity. These problems affect one’s ability 
and efficacy to chew and swallow [37] [38]. 
Subsequently, older people avoid certain 
foods that are hard to chew such as fruit 
and vegetables, or alter the ways they pre-
pare foods such as overcooking vegetables 
to compensate for the difficulty in chewing 
and swallowing, hence compromising their 
intake of key nutrients, e.g. dietary fibre and 
vitamin C [39].
3.5. Gastro-intestinal functions and health
The physiology of the gastro-intestinal (GI) 
tract changes with age, which has a direct ef-
fect on gut functions such as the regulation 
of appetite and satiety. ‘Anorexia of ageing’ 
is a term used to describe reduced appetite 
and food intake in older people, where they 
often eat smaller meals and fewer snacks and 
eat more slowly than younger people [40].
Appetite is largely controlled by the regu-
lation of gut hormones, which are released 
in response to nutritional stimuli. Evidence 
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suggests that with age, the release of specific 
gut hormones is altered, leading to the feel-
ing of satiety as well as suppressing hunger 
[40].
Furthermore, there are physiological chang-
es in the stomach during ageing. Delay in 
gastric emptying accentuates the feeling of 
fullness during meals (satiation) and early 
satiety in older people [41]. Changes in 
the colon also affect the desire to eat, e.g. 
decline in colonic neurons leads to the re-
duction of neural transmitters in the colon, 
affecting its peristaltic and propulsive activi-
ties and increasing bowel transit time [41]. 
Subsequently, these lead to constipation–a 
common complaint observed in old people 
where the abdominal discomfort alters their 
appetite [42].
These physiological changes, together with 
lifestyle factors such as smoking, diet (e.g. 
large meals, fatty foods, caffeine) and medi-
cations (e.g. non-steroidal anti-inflamma-
tory drugs), can lead to pathological con-
sequences in the upper GI tract, including 
gastro-oesophageal reflux disease, peptic 
ulcer and gastric cancer in older people [43]. 
These diseases affect food consumption and 
lead to clinical symptoms including ano-
rexia, weight loss, anaemia, vomiting and 
dysphagia (difficulty in swallowing), which 
increase in severity with advancing age [43].
There are suggestions in the literature that 
ageing leads to distinct changes in the com-
position of the gut microflora, such as reduc-
ing the number and species of many benefi-
cial or protective anaerobes (e.g. bacteroides 
and bifidobacteria) in older gut [44]. The 
downstream effects of changes in the gut 
microflora composition may be increased 
transit time and increased susceptibility to 
disease such as gastroenteritis, or infections 
following antibiotic treatment [44].
3.6. Cognitive functions
Dementia is a disease of the brain that is 
caused by ageing, characterised by a progres-
sive global deterioration in intellect which 
affects memory, thinking, learning, orienta-
tion, language, comprehension, judgement, 
as well as behaviour and the ability to per-
form everyday activities such as shopping and 
cooking [45] [46]. After the age of 65y, the 
risk of developing dementia doubles every 
five years [45]. Alzheimer’s disease (AD) is the 
most common type of dementia, affecting 
one in four people aged 85y+ [47]. Further-
more, cerebrovascular disease and diet-re-
lated diseases and conditions, e.g. diabetes, 
hypertension, obesity and elevated lipid lev-
els, as well as smoking have been shown to 
increase the risk of AD [47]. It is known that 
people with dementia or AD may forget to 
eat or drink, or forget that they have already 
eaten [48]; such behaviours are different ac-
cording to the various stages of dementia 
[49]. For example, at the middle stage of 
dementia, patients appear to have excessive 
hunger or increased appetite; whereas in 
late-stage patients–where one is near total 
dependence and inactivity–often have dif-
ficulty eating and drinking [46] [49], hence 
are most likely to become undernourished.
3. Undernutrition and functional decline in ageing | 17
3.7. Chronic disease and age-related
  illnesses
Older people with chronic diseases, infec-
tions or other disabilities that require long-
term medical treatments are at risk of un-
dernutrition. In addition to disease status, 
 
hospitalisation, medications and their side 
effects (e.g. malabsorption of nutrients, loss 
of appetite, nausea, vomiting, delayed gas-
tric emptying, anorexia and diarrhoea) are 
the major causes of undernutrition in old 
people [50].
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Table 4.1. Summary on evidence selection, its limitations and explanation of study designs.
This chapter reviews the contribution of nu-
trition on AHA. The rationale of evidence 
selection and explanations on the different 
study designs are provided in Table 4.1 to 
aid the interpretation of the evidence pre-
sented. The review begins with the discus-
sions on water and macronutrients (carbo-
hydrate, protein and fat) and their health 
benefits for older people and where avail-
able, health authorities’ recommendations 
on intake levels are provided. Secondly, the 
review pays special attention to a number 
of key micronutrients that are related to 
age-related diseases. As one of the widely- 
used strategies to reduce micronutrient de-
ficiency in older people is to take vitamin 
and mineral supplements to increase nu-
tritional status, therefore the effectiveness 
of micronutrient supplementation on age-
related disease prevention and treatment 
from clinical trials is reviewed. Furthermore, 
phytochemicals and functional foods with 
possible health enhancing properties such 
as probiotics and prebiotics are mentioned. 
Lastly, the evidence on the Mediterranean 
Diet as a whole diet approach in reducing 
mortality rates and chronic disease risks are 
also presented.
4. The role of diet in active and healthy ageing
I. Selection of evidence
The key nutrients (both macro- and micronutrients) presented in the report have been selected based on an existing 
knowledge on ageing including review papers and reports (e.g. the WHO’s Keep Fit for Life published in 2002 [5]).
For macronutrients, if available, recommendations for daily intake for older adults were provided based on pub-
lished European Food Safety Authority (EFSA) scientific opinions.
For the review of micronutrients, the evidence was mainly derived from Cochrane reviews (see Section III of this 
table). In some instances where the Cochrane reviews were dated (e.g. Section 4.6.1.2 vitamin B6 and Section 
4.6.1.3 vitamin B12), evidence from more recent systematic reviews were also provided.
On some rare occasions where Cochrane reviews were not available, evidence was sought from systematic 
reviews first. If those were also unavailable, results from individual clinical trials were mentioned.
For the review on the Mediterranean Diet, only one Cochrane review (2013) was available. Evidence from obser-
vational studies such as prospective cohorts were included mainly because this study design is better suited for 
studying habitual dietary intake and following up free-living individuals to assess mortality rates and disease 
risks.
Readers should bear in mind the methodological limitations of different research approaches (e.g. clinical trials 
vs observational studies) where different study design often lead to different findings and conclusions on the 
same topic. For example, observational studies are prone to selection bias of participants especially in hard-to-
reach populations like the older population. On the other hand, clinical trials usually have much smaller sample 
sizes and apply strict inclusion and exclusion criteria when selecting subjects [51]. Further description on each 
type of research methodology is illustrated below in Section III of this table.
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Table 4.1. (cont.) 
II. Limitations of methodology used in this report
1. Choice of studies presented
The evidence presented in this report was mainly limited to findings from Cochrane reviews, although other 
systematic reviews, meta-analyses, and individual observational and clinical human studies were occasionally 
considered. Evidence from non-human studies, e.g. studies on a range of different organisms, investigating the 
effects of nutrients and bioactive compounds as well as caloric restriction on animal health and lifespan has not 
been considered. In addition, there are an immense number of in vitro, cellular or animal studies that investi-
gate the underlying molecular or cellular mechanisms on how nutrients work to promote healthy ageing. While 
acknowledging their importance in complementing human studies and increasing the plausibility of some of their 
results, these types of studies have also not been considered, as the aim of this report was limited to reviewing 
measurable effects of particular food components on human health in ageing.
2. Recruitment of sample populations
There were no strict definitions imposed on the terms ‘older people’ in many of the studies reviewed, where 
some studies recruited older people from the age of 50 years, 60 years, or some 65 years and older. However, 
this report has not covered the ‘very old’ population, e.g. 85y+, because currently little is known about such popu-
lations since few on-going studies are focussing on the very old. Furthermore, some studies recruited subjects 
from institutionalised settings and some were free-living individuals, some were healthy and some suffered 
from existing chronic conditions. These differences between sample populations make comparisons of study 
results difficult.
3. Nutrients included in this report
Not all nutrients from food were reviewed in this report; only key nutrients that are actively researched in the 
field and have been suggested to play important roles in preventing or delaying the development of age-related 
diseases were selected. For example, alcohol, by definition a nutrient, may have an impact on ageing depending 
on the level of consumption. However, research on alcohol use (or misuse) and its benefits or harm in older peo-
ple is limited and cannot be reported at this stage. Equally, there may be other dietary derived compounds with 
potential health benefits, but it is still too early to establish their efficacy. Furthermore, this report has empha-
sised the evidence from supplementation of nutrients (prone to deficiency) on reducing disease risks and has not 
explored other areas such as food fortification or other non-nutritive supplements for older people, where there 
are few completed scientific research studies to evaluate their efficacy.
4. Lifecycle approach to ageing
The evidence reviewed was based on older people at present. In some cases where longitudinal data were dis-
cussed, earlier years of adulthood might have been accounted for. However, the life course approach to ageing 
was not addressed in this report. Ageing is a life-long process that begins in the womb and how well one will 
age can be modified by a vast number of external influences (nutrition included) throughout life. Pregnancy and 
birth cohort studies can help to unravel such relationships. Currently, there are very few existing birth cohorts 
that have followed participants into adulthood. The oldest British birth cohort – MRC National Survey of Health 
and Development (NSHD) began in 1946 and has to date followed participants up to age 67 years. Birth cohorts 
of such as NSHD are extremely important to further our understanding of ageing, particularly to identify key 
healthy ageing markers at different stages of life.
III. Types of study designs
In clinical research including nutritional sciences, there are two main domains of study design: experimental (e.g. 
randomised controlled trials (RCT)) and observational studies (e.g. prospective cohorts). Figure 4.1 illustrates the 
classification of different types of clinical research, which aids in determining the research methods to undertake 
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Table 4.1. (cont.) 
9. http://www.iarc.fr/en/publications/pdfs-online/epi/cancerepi/CancerEpi.pdf.
10. http://www.cochrane.org/cochrane-reviews.
11. http://www.cochrane.org/about-us/evidence-based-health-care.
12. http://www.cochrane-net.org/openlearning/PDF/Module_12.pdf.
following a number of research criteria [52]. Further reading on the detail of each study design can be found be- 
low.9 In brief, RCTs that are mentioned in this report, are a type of intervention study that are considered the gold 
standard in clinical research, as they help to eliminate bias that other study designs may encounter [52]. Such 
experimental studies are particularly useful, for example, to test the effectiveness of supplementation or a drug 
in treating a condition in a study population, where the subjects are randomly assigned to ‘treatment’ or ‘control’ 
groups, and the latter does not receive the real treatment but a placebo pill. The two groups are then com-
pared after the intervention to identify if the treatment worked. On the other hand, cohort studies are a type of 
observational study that investigates the risk of developing a disease or condition in a large population (cohort) 
that is exposed to a particular factor compared to another population without this exposure, but otherwise both 
populations share similar characteristics. These two groups are followed forward in time to determine the risk of 
an outcome based on this exposure factor [52]. This type of study furthers our understanding on the relationship 
between exposures and disease development. However, results should be interpreted with caution as there are 
usually confounding factors that may interfere the relationship between exposure and outcome.
Figure 4.1. Algorithm for classification of types of clinical research [52]. Reprinted from D.A. Grimes, K.F. Schulz:  
‘An overview of clinical research: the lay of the land’, The Lancet, Vol. 359 (9300), pp. 57-61 (copyright 2002, 
with permission from Elsevier).
Reviews (including Cochrane reviews, systematic reviews and meta-analyses) gather results from individual 
research studies and examine the overall strength of the evidence between the exposure factor, e.g. intake of 
a nutrient, and the outcome, e.g. risk of a disease. Cochrane reviews are a particular type of systematic review 
of primary research in human health care and health policy that are internationally recognised as the highest 
standard in evidence-based health care.10 A systematic review is a high-level overview of primary research on 
a particular research question that tries to identify, select, synthesise and appraise all high-quality research evi-
dence from relevant studies in order to answer the question.11 A meta-analysis is the use of statistical techniques 
to combine the results of a systematic review. This allows the best use of all the information gathered in a 
systematic review by increasing the power of the analysis.12
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4.1. Water
Adequate water intake is one of the key fac-
tors to prevent chronic diseases and to fight 
infections in older people [53] [54]. In fact, 
water is essential for normal bodily func-
tions including absorption and distribution 
of nutrients, thermoregulation and the ex-
cretion of wastes [54].
Dehydration is a frequent cause of morbid-
ity and mortality in old people [54]. Stud-
ies have shown that even mild dehydration 
may have an adverse effect on urinary stone 
recurrence and broncho-pulmonary and re-
nal disorders [53] [55]. Unfortunately, dehy-
dration is common and often overlooked in 
the older population. Because older people 
are less sensitive to thirst and tend to have 
reduced food intake (e.g. fruit and vegetable 
consumption contributes a proportion of 
daily water intake), it is recommended that 
they should drink at least 1.5 l of water per 
day [5]. To be more accurate, the WHO indi-
cated that a normal weight adult requires an 
intake of 30 ml of water per kilogram body 
weight per day [5]. However for underweight 
adults, an intake of 100 ml/kg for the first 
10 kg weight, 50 ml/kg for the next 10 kg and 
15 ml/kg for the remaining weight is more 
appropriate to prevent dehydration [56]. It is 
recommended that older people be offered 
small quantities of water and liquids regular-
ly throughout the day and not to consume 
large amounts of fluids at once [57].
4.2. Energy
Starting from the age of 50y, energy require-
ments are on a gradual decline due to re-
duced total energy expenditure (TEE) [58]. 
TEE is determined by two main factors–ba-
sal metabolic rate (BMR), the body’s inter-
nal energy requirement for normal physi-
ological functions when a person is at rest; 
and physical activity level (PAL), the extra 
energy the body requires when doing extra 
work, such as exercising. With age, BMR is 
reduced as a result of changes in body com-
position–namely a decline in lean body mass 
(mainly muscles) and increase in body fat 
mass [59]. Because muscles are more meta-
bolically active than fat (i.e. 1 kg of muscle 
burns more calories than 1 kg of fat), older 
people require fewer calories at rest than 
their younger counterparts. Previous stud-
ies have suggested that for every decade of 
life, the BMR of a person with normal body 
mass index 13 will reduce by 2.0% for women 
and 2.9% for men [58]. Similarly, PAL also 
decreases with increasing age. This is due to 
older people being less physically active than 
younger people, for reasons such as frailty 
and reduced mobility. The contribution to 
TEE from PAL is generally quite small, unless 
the individual is exceptionally active and fit 
for their age, in which case their BMR would 
also be higher due to higher lean body mass.
13. Body mass index (BMI) is a simple index of weight-for-height 
that is commonly used to classify underweight, overweight and 
obesity in adults. BMI values are age-independent and the same 
for both sexes. Classifications are as follow: underweight–BMI 
< 18.50 kg/m2; normal weight–BMI ≥ 18.50 kg/m2; overweight–
BMI ≥25.00 kg/m2; obese–BMI ≥30.00 kg/m2. For further reading 
and the method of calculation, consult: http://apps.who.int/bmi/
index.jsp?introPage=intro_3.html. 
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Table 4.2. Average requirement for energy (kcal/day) 
by physical activity level for European adults. Adapted 
from EFSA 2013 [61].
It is important that older adults acquire 
enough energy from their diet to prevent 
undernutrition and related conditions, in-
cluding impaired immune response, im-
paired muscle and respiratory function, de-
layed wound healing, longer rehabilitation, 
greater length of hospital stay and increased 
mortality [60]. The EFSA recently published 
a scientific opinion on dietary reference val-
ues for energy for the European population 
[61]. The average energy requirement for 
men and women of different ages according 
to their PAL is shown in Table 4.2 [61]. Aver-
age energy requirements were not calculated 
for older people aged 80y+ because of a lack 
of anthropometric data from EU countries 
for this age group [61].
4.2.1. Calorie restriction
Calorie restriction (CR), a reduction in en-
ergy intake without malnutrition or com-
promised intake of other key nutrients, has 
been shown to increase healthy lifespan 
of a range of organisms such as yeast, flies, 
worms, rats and monkeys, as well as to pro-
tect them against age-related functional 
decline and diseases [62]. Whether CR has 
the same effect on human longevity as in 
other organisms is not yet clear, although 
there are some indications that CR may 
reduce risk factors for diabetes, CVD and 
cancer [62]. Importantly however, if CR is 
not performed appropriately, detrimental 
health effects such as sarcopenia, osteopo-
rosis and immune deficiencies may occur 
[62]. Therefore, without critical evaluation 
of the evidence on human CR intervention 
studies and further recommendations from 
health authorities, the practice of CR is not 
suggested to the general public at this stage. 
4.3. Protein
Sufficient intake of protein is important to 
maintain lean body mass and to slow down 
and possibly prevent musculoskeletal con-
ditions such as sarcopenia and osteoporosis 
[63]. Protein, which is made up of amino 
acids, is one of the building blocks of mus-
cle fibres and bones. Studies have suggested 
that ingestion of moderate to large portions 
of amino acids can promote muscle protein 
synthesis in both young and old healthy 
subjects [64]. However, with age, the abil-
ity of skeletal muscle to respond to protein 
is less efficient, particularly when the level 
Age (years) Average requirement (kcal/day) for energy by PAL
Sedentary Moderately 
active
Active Very active
Men
18-29 2 338 2 672 3 006 3 340
30-39 2 264 2 588 2 911 3 235
40-49 2 234 2 553 2 873 3 192
50-59 2 204 2 519 2 834 3 149
60-69 2 017 2 305 2 593 2 882
70-79 1 984 2 267 2 550 2 834
Women
18-29 1 878 2 147 2 415 2 683
30-39 1 813 2 072 2 331 2 590
40-49 1 798 2 055 2 312 2 569
50-59 1 783 2 037 2 292 2 547
60-69 1 628 1 861 2 093 2 326
70-79 1 614 1 844 2 075 2 305
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of essential amino acids (EAAs) ingested 
is very low [64]. Older adults need higher 
(10- 15 g/day) consumption of EAAs to have 
the same degree of stimulation of muscle 
protein synthesis as their younger counter-
parts [64]. Several research studies have in-
vestigated the effects of supplementation of 
leucine, an EAA that plays a role in stimu-
lating insulin secretion and muscle protein 
synthesis, on the prevention of sarcopenia 
in older people. However, the results to date 
have been inconclusive; especially in acute-
ly ill and frail older patients [64].
Because protein metabolism may be less ef-
ficient with increasing age, it has been sug-
gested that older people may need to increase 
their protein intake to prevent muscle loss 
and malnutrition. It is not clear the effect 
of increasing protein intake in healthy older 
adults; however a Cochrane review (2009) 
examined the effects of protein and energy 
supplementation in those at risk of malnu-
trition in sixty-two clinical trials, the results 
showed that supplementation produced a 
small (2.2%) weight gain in older people in 
42 trials, and in a small sample of older peo-
ple who were already malnourished, mortal-
ity rate was reduced when they were supple-
mented with protein and energy [60].
In 2012, EFSA reviewed the evidence to es-
tablish whether there is a need for a higher 
protein recommendation for the older pop-
ulation. At the time, there were few studies 
available on the long term health effects of 
high protein intake in healthy older adults 
(such as on kidney function). Therefore, it 
was not possible for EFSA to establish a 
higher protein intake recommendation for 
older adults and it currently remains at the 
same level as for younger adults–at 0.8 g/kg 
per day– i.e. a 75 kg healthy adult would 
need 60 g of protein per day [64] [65]. There 
is a continual debate on protein intake and 
recommendation for older people nonethe-
less, where a recent study (2013) reviewed di-
etary protein needs in older people and rec-
ommended an average daily intake of 1.0 - 1.2 
g/kg per day for those aged 65y+ and even 
higher intake for those who are exercising 
and otherwise active [66].
4.4. Fat
Fat is the most energy-dense 14 nutrient, i.e. 
it contains the most calories per gram [67]. 
It is an important energy source and facili-
tates the absorption of fat-soluble vitamins 
A, D, E and K, and has vital structural and 
regulatory functions in the human body. 
However, because of its high energy density, 
overconsumption of fat can lead to exces-
sive total energy intake, which promotes 
overweight and obesity [68]. Furthermore, 
the consumption of trans fatty acids (TFA) 
is found to have adverse effects on cardio-
vascular health [69]. On the other hand, 
monounsaturated (MUFA) and polyunsat-
urated (PUFA) fatty acids are suggested to 
have beneficial effects on human metabolic 
health such as improving cardiovascular risk 
[70] [71] and insulin sensitivity [71] [72] 
[73], although the current evidence is some-
what stronger for PUFA than MUFA [71].
14. Energy density of macronutrients: Carbohydrate–4 kcal/g; 
Protein–4 kcal/g; Fat–9 kcal/g; Alcohol–7 kcal/g.
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In recent years, long-chain omega-3 fatty 
acids (n-3 fatty acids) have been proposed 
to have protective effects on brain health 
through reducing oxidative stress and in-
flammation [74] and therefore may have 
implications on brain function in ageing 
adults. Thus far, the evidence mainly comes 
from cross-sectional and longitudinal ob-
servational studies that demonstrated some 
encouraging effects of n-3 fatty acids on cog-
nitive function in healthy older adults; the 
evidence from intervention studies is less 
clear. One review found that 19 out of 26 
studies of various study designs observed 
positive relationships between fish con-
sumption or n-3 fatty acids intake (from diet 
or supplement) and cognitive status while 
the other seven studies found either little 
or no beneficial effects [75]. The evidence 
on supplementation from clinical trials is 
weaker, a review on clinical trials found only 
one RCT out of seven supported beneficial 
effects from n-3 fatty acids supplementa-
tion and the prevention of dementia and 
cognitive decline [76]. Furthermore, a re-
cent Cochrane review (2012) examining the 
evidence from three n-3 fatty acids supple-
mentation trials found no beneficial effect 
of supplementation on cognitive function 
or prevention of dementia and that clinical 
trials of longer duration were needed before 
a final conclusion could be drawn [77].
Long chain n-3 fatty acids have been pro-
posed to have other health-promoting prop-
erties in normal ageing, including immune 
function, bone and muscle health [75]. Sev-
eral clinical studies have found that even 
low doses of n-3 fatty acids supplementation 
can influence immune response in older 
people [75]. A systematic review of 23 clini-
cal trials found a modest, but fairly consist-
ent benefit of fish oil containing n-3 PUFA 
on joint swelling and pain associated with 
rheumatoid arthritis [77]. In addition, re-
duced duration of morning stiffness as well 
as improvement in other indicators of the 
disease were found [78]. Very few studies 
have examined the relationships between 
n-3 fatty acids and musculoskeletal health so 
far; however, a review which identified three 
relevant studies has found protective effects 
[75]. Further studies are needed to confirm 
such relationships.
Currently, there is no specific recommen-
dation related to dietary fat intake for older 
adults. For European adults, EFSA has pro-
posed a reference intake range of 20 to 35 
percent of daily total energy (E%) from fat 
[79]. For saturated fatty acids and TFA, in-
take should be as low as possible within the 
context of a nutritionally adequate diet [79]. 
The EFSA panel also proposed setting ‘Ad-
equate Intake’ levels for specific n-3 and n-6 
fatty acids including: linoleic acid (n-6 fatty 
acids) of 4 E%, alpha-linolenic acid (n-3 fatty 
acids) of 0.5 E%, and eicosapentaenoic acid 
plus docosahexaenoic acid (n-3 fatty acids) 
of 250 mg/day for health-protective benefits 
in adults [79].
4.5. Carbohydrates
Little is known regarding the role of car-
bohydrates in healthy ageing. Although 
glucose is an important energy source for 
the brain, a recent Cochrane review (2011) 
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concluded there is insufficient evidence for 
the use of carbohydrates to improve cogni-
tive performance in older adults with nor-
mal or mild cognitive impairment (MCI), 
due to limited studies in the area [80]. On 
the other hand, there is some evidence from 
observational studies to link diabetes with 
cognitive decline including memory and ex-
ecutive functions [81] [82] [83]; particularly 
in older diabetics (aged 65y+), who are more 
likely to have cognitive decrements and to 
score lower in cognitive tests than younger 
diabetics [82]. Nonetheless, previous stud-
ies have suggested that controlling blood 
glucose may help prevent cognitive decline 
[84], although further evidence is needed to 
clarify this.
In terms of recommendation of carbohy-
drates intake, there is no specific guidance 
for older adults. EFSA proposed a refer-
ence intake range of 45-60 E% from carbo-
hydrates [85]. For sugars, EFSA noted that 
there is insufficient data to allow the setting 
of an upper limit for ‘total’ or ‘added sug-
ars’ intake in the EU. There are, however, 
some EU countries which have established 
upper limits for population average intake 
or individual intake of added sugars of 
less than 10 E%, based on WHO’s current 
recommendation,15 in order to discourage 
high consumption of added sugars [85].
15. http://www.who.int/mediacentre/news/notes/2014/consulta-
tion-sugar-guideline/en/.
4.6. Micronutrients
Older adults are particularly susceptible to 
deficiencies in various micronutrients due 
to reduced intake of foods that are rich in 
vitamins and minerals. The prevalence of 
deficiency and undernutrition is highest 
amongst the very old, women, and those in 
care homes and institutions [86] [87]. Mi-
cronutrients are essential to maintaining 
normal physical and cognitive functions in 
the ageing body and inadequate intakes will 
subsequently lead to deterioration of health 
and to the development of certain diseas-
es. The function of micronutrients and the 
consequences of deficiency are summarised 
in Table 4.3. Further discussion on the effec-
tiveness of micronutrient supplementation 
on age-related disease prevention and treat-
ment based on clinical studies are described 
below.
4.6.1. Vitamins B6, B12 and folic acid
There has been a growing interest in supple-
mentation of three B vitamins – B6, B12 and 
folic acid (henceforth B-vitamins) in relation 
to a number of age-related vascular diseases 
due to their role in homocysteine metabo-
lism. Homocysteine is an amino acid that, 
at high levels, is considered an independ-
ent risk factor for vascular diseases. Previous 
epidemiological studies on B-vitamin status 
and cognition found that older people with 
elevated homocysteine levels (hyperhomo-
cysteinaemia) tend to have lower B-vitamin 
status, as well as lower cognitive tests scores 
[101] [102]. They were also at higher risk of 
vascular diseases including dementia and 
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AD [103] [104] [105] [106] than those who had 
normal homocysteine or B-vitamin status. 
These observations sparked the theory that 
 
adequate intake of these vitamins can lower 
homo-cysteine levels, resulting in the pre-
vention of these diseases. A number of RCTs 
Table 4.3. Function of essential micronutrients prone to deficiency in older people and health consequences.
Vitamin B6 Main function: essential for normal homocysteine metabolism, normal energy-yielding metabolism, 
normal psychological functions, normal cysteine synthesis [88]; regulation of mental function and 
mood [89].
Deficiency associated with: an increase in blood homocysteine levels–a risk factor for cerebrovas-
cular disease and possible toxic effects on the central nervous system; high homocysteine levels 
are possibly involved in the development of AD and other forms of dementia in older people [89]; 
neuropsychiatric disorders including seizures, migraine, chronic pain and depression [89].
Vitamin B12 Main function: red blood cell formation, neurological function and DNA synthesis [90].
Deficiency associated with: an elevated homocysteine level similar to B6 deficiency–impact on 
cognition and cardiovascular health, neurological changes including poor memory and confusion, 
anaemia, decreased muscle strength and functional disability [90] [91].
Folic acid Main function: involvement in the synthesis of nucleic acids (DNA and RNA), cell division and me-
tabolism of amino acids [92].
Deficiency associated with: anaemia (megaloblastic anaemia); elevated homocysteine as seen in B6 
and B12 deficiency–possibly related to development of dementia, AD, depression and CVD [92].
Vitamin D Main function: bone metabolism, promotes calcium absorption, and calcium and phosphorus ho-
meostasis [93]; other roles include renal production of renin, insulin secretion, an active metabolite of 
vitamin D which regulates the transcription of a large number of genes [94].
Deficiency associated with: calcium malabsorption, increased risk in bone-related conditions (frac-
tures, osteoporosis, osteomalacia), muscle weakness, CVD, metabolic syndrome and overall mortality 
[93] [95].
Calcium Main function: maintenance of healthy teeth and bones, cell signalling, coagulation, muscle contrac-
tion and neural transmission [96].
Deficiency associated with: an increased bone loss and an increased risk of fracture; long-term 
calcium deficiency can confer predisposition to osteoporosis [97].
Antioxidant
vitamins 
A, C, E
Main function: neutralise the excess of free radicals, to protect the cells against their toxic effects 
and to contribute to disease prevention [98].
Deficiency associated with: numerous chronic and degenerative pathologies such as cancer, autoim-
mune disorders, aging, cataract, rheumatoid arthritis, cardiovascular and neurodegenerative diseases 
[98].
Selenium Main function: exert antioxidative and anti-inflammatory properties when incorporated into protein 
and form various selenoproteins [99].
Deficiency associated with: an increased risk of mortality, poor immune function and cognitive 
decline [99]. 
Zinc Main function: normal growth and development, neurological function, wound healing and immune 
function [100].
Deficiency associated with: an increased susceptibility to infections; diarrhoea; dermatitis [100]; 
reduced taste acuity [33].
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have since been undertaken to examine the 
effectiveness of B-vitamin supplementation 
on cognitive function and other vascular 
disease outcomes. To date, relatively few 
trials have investigated the vitamins inde-
pendently and most have had little success 
on preventing or treating cognitive decline. 
This section discusses the current evidence 
for each of the three vitamins, as well as the 
effects of multi B-vitamins on cognition or 
vascular disease.
4.6.1.1. Vitamin B6. A Cochrane review (2003) 
on the effect of vitamin B6 supplementa-
tion on cognition identified only two rel-
evant trials in healthy older adults [89]. One 
study found no significant effect on mood 
or cognition from supplementation in older 
women [107]; the other found a modest but 
significant effect of vitamin B6 on long-
term memory in older men, yet no improve-
ments on other cognitive measures [108]. 
Due to the limited number of studies and 
very few subjects, the authors of the review 
concluded there is insufficient evidence to 
support the beneficial effects of vitamin B6 
in improving mood or cognitive function.
A separate review examined the effects of 
vitamin B6 supplementation and the pre-
vention of CVD recurrence in clinical trials. 
Similar to the cognition studies, the collec-
tive results failed to show positive effects, 
despite relatively consistent associations be-
tween low vitamin B6 status and CVD inci-
dence in epidemiological studies [109].
4.6.1.2. Vitamin B12 A Cochrane review, 
conducted in parallel with the review for 
vitamin B6 (2003), examined the effect of 
B12 supplementation on cognitive function 
of demented versus healthy elderly people, 
to prevent the onset or progression of cog-
nitive impairment or dementia [110]. The 
results, which included two trials, did not 
show improvements in cognitive functions 
in older adults with dementia [110]. A more 
recent review (2010) of seven intervention 
studies showed no effect of B12 supplemen-
tation on cognition in six studies, while 
one study found some improvement in the 
intervention group on the performance of 
verbal word learning test but not in other 
cognitive tests [111].
4.6.1.3. Folic acid At present, the effects of 
folic acid supplementation on cognition are 
inconclusive. A Cochrane review (2008) of 
eight clinical trials (of which four included 
healthy older adults and four trials recruit-
ed those with mild to moderate cognitive 
impairment or dementia), did not find 
consistent evidence that folic acid (with or 
without B12) can improve cognitive func-
tion or mood [112]. One trial in the review 
however, which recruited healthy older 
adults with raised homocysteine level (but 
normal serum vitamin B12), found that af-
ter the three-year intervention period, the 
folic acid supplementation group had lower 
homocysteine level and better performance 
in various cognitive tests (memory, infor-
mation processing speed and sensorimotor 
speed) than the control group [113]. Despite 
that long-term use of folic acid supplemen-
tation appeared to improve the cognitive 
function of healthy older people with high 
homocysteine levels, the Cochrane review 
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concluded more studies with positive find-
ings and longer study durations are needed 
to warrant its effectiveness [112].
4.6.1.4 Multi B-vitamin studies Clinical tri-
als with single vitamin supplementation 
have not demonstrated their efficacy in im-
proving cognitive function in older people. 
A number of trials have since investigated 
the effectiveness of combined B-vitamin 
supplementation. A systematic review con-
ducted in 2007 assessed the evidence from 
six trials that supplemented combined B-
vitamins (B6, B12 and folic acid or B12 with 
folic acid) to healthy and unhealthy older 
adults (with dementia or ischaemic vascular 
disease) [114]. One study using the combi-
nation of all three B-vitamins found some 
improvement in one out of eight cognitive 
tests. Other trials found no dose-response 
relationships or that the controls performed 
better than the intervention groups [114]. 
Recent studies have shown some positive 
results, albeit not consistent. A small inter-
vention trial on subjects with MCI found 
that combined B-vitamin supplementation 
slowed the rate of accelerated brain atrophy 
[115], as well as slowing cognitive decline es-
pecially in subjects with elevated homocyst-
eine level [116]. In a larger trial of commu-
nity-dwelling 16 older adults with depressive 
symptoms, a combination of folic acid and 
B12 for two years improved some aspects of 
cognitive functioning in older adults [117]. 
However, there were also a number of stud-
ies that found no effects of multi B-vitamin 
16. Community-dwelling older adult are those who are not in as-
sisted living or nursing homes.
supplementation on the risk of cognitive 
impairment or dementia in healthy people 
or those with vascular disease [118] [119].
There is discordance between the associa-
tions found between low B-vitamin status or 
elevated homocysteine levels and vascular 
disease risk in observational studies and the 
lack of efficacy of B-vitamin supplements in 
such diseases in clinical trials. Differences in 
the dose of supplements used in studies, the 
duration of the interventions, the possibil-
ity of an unknown therapeutic window for 
the supplements to be effective, compliance 
of the subjects, and the variations in indi-
vidual responses to interventions between 
subjects are some of the potential reasons 
for the lack of beneficial effects seen in vari-
ous clinical studies [120]. The differences in 
results between clinical and observational 
studies could be due to the varying chemi-
cal forms and bioavailability between B-
vitamins from supplements and from food 
sources. In addition, the combination of 
nutrients obtained from food (as seen in 
observational studies) may have interactive 
and synergistic effects on health; such ben-
eficial effects may be absent in supplemen-
tation trials.
4.6.2. Vitamin D and calcium
Vitamin D and calcium are well known for 
their important roles in bone health. Calci-
um is an essential architectural component 
of bones and teeth–where 99% of total body 
calcium is found [96]. Vitamin D plays a 
role in calcium absorption and maintaining 
serum calcium and phosphorus homeosta-
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sis [94]. When vitamin D status is low, calci-
um absorption is disturbed and triggers the 
compensatory release of a specific hormone 
called parathyroid hormone that promotes 
bone resorption and accelerates bone loss 
[121]. Vitamin D is synthesised in the skin 
by the action of UVB light from the sun. 
However in older people, the production of 
vitamin D from sun exposure is limited due 
to the reduction of vitamin D precursor in 
the ageing skin and also the time spent out-
door is usually lower in older people [122]. 
Therefore, in older adults who are prone to 
deficiency, increasing intake of vitamin D is 
important for bone health.
A Cochrane review (2009) evaluated the ef-
fects of vitamin D supplementation with or 
without calcium in preventing bone frac-
tures in older adults. The review which in-
cluded 45 clinical trials and more than 84 000 
participants found that vitamin D alone ap-
peared to have little effect on the risk of frac-
tures [123]. In trials where subjects were sup-
plemented with vitamin D and calcium, hip 
fractures reduced by 16%. However, further 
analysis showed it was mainly older people 
in institutional care that had a significant 
reduction in hip fractures but not the older 
adults in community-dwelling. Furthermore, 
subjects who received an active form of vi-
tamin D3 (calcitriol) 17 as supplements were 
more susceptible to elevated calcium in 
blood (hypercalcaemia) and experiencing 
gastrointestinal symptoms and renal disease 
17. Vitamin D3 is synthesised in the skin as cholecalciferol or is 
obtained from dietary sources or supplements as alfacalcidol and 
calcitriol.
[123]. Another Cochrane review (2011) fur-
ther evaluated the evidence on various types 
of vitamin D supplementation and preven-
tion of mortality. A specific form of vitamin 
D (cholecalciferol) appeared to decrease 
mortality in predominantly older women 
who were in institutions and dependent care, 
whereas other forms had no effect on mor-
tality. This review also found that active 
forms of vitamin D3–alfacalcidol and cal-
citriol–increased the risk of hypercalcaemia 
significantly, and that combining vitamin D 
and calcium in supplements increased the 
risk of kidney stone formation [124].
Calcium and vitamin D supplementations 
are often used in postmenopausal women 
to prevent osteoporosis. While some stud-
ies have indicated such supplements, in par-
ticular calcium, may be related to increased 
rates of cardiovascular events seen in older 
women [125], both observational studies 
and clinical trials have shown inconsistent 
results. In 2012, the EFSA Panel on Dietetic 
Products, Nutrition and Allergies evaluated 
the existing data to determine a tolerable 
upper intake level of calcium. In relation to 
its risk on CVD, the Panel concluded that, 
calcium intakes up to about 2 000 mg/day 
from food and supplements have not been 
associated with an increased risk of CVD 
events [96]. Furthermore, the Panel con-
cluded that long-term calcium intakes from 
diet and supplements up to 2 500-3 000 mg/
day are not associated with an increased risk 
of CVD in all adults [96].
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4.6.3. Vitamins A, C and E 
   –antioxidant vitamins
The mitochondrial free radical theory of 
ageing was proposed several decades ago 
and has been actively investigated [126]. Free 
radicals are produced in the mitochondria 
during respiration [98] and, if in excess, they 
cause oxidative damage in cells and tissues, 
which over time, has been hypothesised to 
lead to the development of a number of age-
related degenerative conditions including 
AD, dementia, cancer, CVD and AMD [98] 
[127] [128]. To protect cells from damage, an-
tioxidants are needed to neutralise free radi-
cals through a series of chemical reactions 
[98]. Antioxidants come from two sources: 1) 
the body’s internal production or 2) through 
the intake of antioxidant nutrients, such as 
vitamins A, C and E, as well as a number of 
polyphenolic compounds [98]. Reviews of 
epidemiological studies have indicated that 
consuming a diet rich in antioxidants may 
lower CVD risk [129], the risk of cognitive 
decline, AD and dementia [130], as well as 
age-related eye diseases [131].
Numerous clinical investigations have since 
been undertaken to determine whether an-
tioxidant supplementation can prevent or 
slow down the progression of various age-re-
lated diseases, particularly cognitive impair-
ment, AMD and cataracts. One Cochrane 
review (2012) investigated the use of vitamin 
E and beta-carotene to prevent the devel-
opment of AMD and found no effects in 
preventing the condition in over 60 000 trial 
participants [132]. A similar Cochrane review 
(2012) was performed on subjects with exist-
ing AMD to determine whether antioxidant 
supplementation (beta-carotene, vitamins C 
and E and zinc) could slow down AMD pro-
gression. In trials with a short follow-up du-
ration, there were no beneficial effects seen 
from the use of supplements. One large trial 
on the other hand, found that subjects tak-
ing antioxidant supplements were less likely 
to lose visual acuity over the 6.3 years of fol-
low-up [128]. However, because of inconsist-
encies in the results across the trials, it was 
concluded that the effects of antioxidants 
on reducing the risk of AMD progression 
were only moderate [128]. In terms of age-
related cataracts, another Cochrane review 
(2012) found no evidence that supplementa-
tion with beta-carotene, vitamins C or E can 
prevent or slow the progression of cataracts, 
despite including over 117 000 subjects with 
considerable durations of follow-up between 
2 to 12 years [133].
There is also little evidence to support the 
use of vitamin E to improve cognitive func-
tion or to protect against the development 
of brain disease. A Cochrane review (2012) 
assessed the efficacy of vitamin E in treating 
AD and preventing the progression of MCI 
to dementia [134]. Three trials were included 
of which two were based on patients with AD 
and the other recruited subjects with MCI. 
One of the AD studies found some benefi-
cial effects on patients when a high-dose of 
vitamin E (2 000 IU/day) was administered. 
The other AD study used a lower dose of 
vitamin E (800 IU/day) and detected lower 
oxidative stress in some patients but overall 
there were no differences in cognitive test 
scores between the test and control groups. 
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For subjects with MCI, high-dose vitamin 
E (2 000 IU/day) had no effects on slowing 
down the progression of MCI to AD [134].
A recent systematic review and meta-analysis 
of RCTs investigated the efficacy of vitamin 
and antioxidant supplements in prevention 
of CVD. Fifty clinical trials with approxi-
mately 300 000 subjects were included in 
the review. Similar to the abovementioned 
Cochrane studies, the authors found no 
evidence to support the use of vitamin and 
antioxidant supplements to prevent CVD 
[135]. Another meta-analysis also found no 
positive effects of vitamins A, C and E sup-
plementation and the incidence of major 
cardiovascular events and mortality [136].
There are discussions regarding the safety of 
antioxidant vitamin supplements as a num-
ber of previous clinical trials have indicated 
taking antioxidant supplements beyond the 
body’s needs may increase mortality. A 
Cochrane review (2012) assessed the risk of 
increased mortality from taking antioxidants 
in 56 clinical trials on healthy subjects. It was 
found that the intake of beta-carotene, vita-
min E and high doses of vitamin A supple-
ments correlated significantly with increased 
mortality [137]. Some clinical trials found 
smokers taking beta-carotene supplements 
were at higher risk of lung cancer than con-
trols [138]. Several trials in the abovemen-
tioned Cochrane reviews have also observed 
yellowing of skin in participants taking an-
tioxidants, in particular beta-carotene [133].
4.6.4. Other antioxidants
   –selenium and zinc
Selenium is a trace element that has anti-
oxidative and anti-inflammatory properties 
when incorporated into certain proteins to 
form selenoproteins [99]. Dietary sources of 
selenium vary vastly between countries, but 
usually include meat and offal, fish, eggs, 
grains and cereals, as well as certain fruits 
and vegetables (garlic bulbs, onion and broc-
coli), and Brazil nuts [99] [139]. This trace 
element is less well-researched compared to 
vitamin antioxidants, however it has been 
suggested that selenium may have a benefi-
cial effect on lowering gastrointestinal can-
cer occurrence [140]. Low selenium status 
may also be associated with increased risk of 
mortality, poor immune function and cog-
nitive decline [99]. Similar to the use of anti-
oxidant vitamin supplements, some studies 
have indicated that the use of selenium sup-
plements in people with normal selenium 
status may be detrimental, e.g. by increasing 
the risk of type 2 diabetes [99]. A Cochrane 
review (2013) found limited evidence on the 
use of selenium supplementation to prevent 
CVD events or related mortality [141]. Over- 
all, more rigorous clinical trials are needed 
to confirm the link between selenium intake 
and its effects on various age-related diseases.
Zinc is also a micronutrient that can have an-
tioxidative functions in the body. It has been 
suggested that zinc deficiency is linked to neu-
ronal damage seen in AD, as zinc may be im-
portant in lowering the level of copper in the 
brain, which in excess, can act as a pro-oxidant 
and may increase the risk of AD [142]. How-
32 | The Role of Nutrition in Active and Healthy Ageing
ever, there is a lack of consistent evidence to 
confirm this link. Zinc has also been suggest-
ed to be potentially beneficial for eye health. 
A systematic review assessed the evidence on 
zinc in preventing and treating AMD [143]. 
One RCT showed that zinc supplementation 
significantly reduced the risk of progression to 
advanced AMD, two RCTs showed positive 
results in visual acuity in older people with 
early AMD and the remaining RCT showed 
no effect. The results from the cohort studies 
on the other hand, were inconsistent on zinc’s 
role in AMD prevention [143].
Zinc has an essential role in the immune sys-
tem. It is known that the immune system un-
dergoes alterations with advancing age; the 
ability to respond to infections and to de-
velop immunity after vaccination deteriorate 
with age and leads to a higher risk of mortali-
ty caused by infections in older people [144]. 
One small RCT with fifty elderly subjects 
investigated the effectiveness of 12 months 
supplementation of zinc and the incidence 
of infections. Zinc supplementation was able 
to reduce oxidative stress in the treated sub-
jects and their mean infection incidence was 
also lower than in the controls [145]. These 
results and zinc’s potential role in reducing 
infections and related mortality are encour-
aging. However, more research is needed, as 
currently, there are very few studies in this 
area with a specific focus on older people.
Old people are more susceptible to upper 
respiratory diseases–the leading cause of 
death due to infections [146]. A Cochrane 
review (2013) assessed the role of zinc in 
treating common colds [147]. Rhinovirus 
is responsible for around 80% of common 
colds and it has been suggested that zinc 
may exert an antiviral effect by attaching it-
self to the virus and blocking its action in 
infecting the nasal cells [147]. It was found 
that when zinc was taken within 24 hours 
of onset of the cold, the average duration 
of the symptoms in healthy people was re-
duced, and their symptoms were less likely 
to persist beyond seven days of treatment, 
but there were no differences in the severity 
of symptoms between the treatment and the 
control groups [147]. However, the authors 
warned to interpret the results with caution 
due to the variability of methods used be-
tween studies [147].
4.7. Phytochemicals
4.7.1. Catechins
There has been widespread interest in the 
role of certain antioxidative phytochemicals 
to prevent chronic diseases. Tea leaves for ex-
ample, contain catechins–a family of poly-
phenolic compounds which are believed to 
have strong antioxidative properties [148]. 
Various clinical trials have studied the effects 
of tea catechins, mainly from green tea, on 
the prevention of CVD and cancer as well 
as weight loss. A Cochrane review (2013) in-
vestigated the effects of green and black tea 
on CVD risk factors in eleven RCTs. Black 
tea was found to lower low-density lipopro-
tein (LDL) cholesterol and blood pressure, 
whereas green tea was associated with lower 
total cholesterol, LDL and blood pressure 
[149]. However, the long-term effects of tea 
and CVD events remained unclear due to 
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a lack of trials of sufficiently long duration, 
although one Australian prospective study 
found that older women aged 75 years and 
older with a habitual high intake of poly-
phenols from tea over a five year period had 
a lower risk of CVD death [150]. Another 
Cochrane review (2009) assessed the rela-
tionship between green tea catechins and 
cancer prevention. The studies included in 
the review were of mixed quality, varied in 
methodologies and reported conflicting re-
sults regarding incidence of cancer. Overall, 
there was not enough evidence to support 
drinking green tea to prevent cancer; how-
ever, the authors concluded that regularly 
drinking three to five cups or up to 1.2 l/
day (providing 250 mg/day of catechins) ap-
peared to be safe [151].
4.7.2. Resveratrol
Resveratrol is another antioxidative poly-
phenol molecule that is found in grape skins 
and seeds, and medicinal plants and its in-
take is mainly from red wine [152]. Previous 
studies have shown that resveratrol could 
increase lifespan, lower fasting glucose, im-
prove insulin sensitivity, prevent liver dam-
age and improve performance in animals 
(e.g. invertebrates and mice) [152]. Because 
of the health benefits seen in animals, it is 
believed that resveratrol may have similar 
effects in humans. Currently, resveratrol is 
being actively investigated in human clini-
cal studies. So far, no Cochrane review has 
been conducted to assess the evidence on 
possible health effects of this molecule. 
In one comprehensive review on resvera-
trol and human health, the authors wrote 
that ‘the evidence is sufficiently strong to 
conclude that a single dose 18 of resveratrol 
is able to induce beneficial physiologic re-
sponses, and that either weeks or months 
of resveratrol supplementation produces 
physiologic changes that are predictive of 
improved health, especially in clinical pop-
ulations with compromised health’ ([153], p. 
1 138). Despite such conclusions, further me-
ta-analyses are needed to critically assess the 
combined effects of resveratrol on different 
aspects of human health. It is too early to 
determine the efficacy of resveratrol supple-
mentation in increasing lifespan or prevent-
ing chronic diseases in humans, particularly 
in the long-term.
4.7.3. Other bioactive compounds
There are on-going research studies on other 
polyphenolic compounds with antioxida-
tive and anti-inflammatory properties, such 
as anthocyanins found in berries, grape 
seeds and blood oranges, as well as glucosi-
nolates found in cruciferous vegetables, e.g. 
broccoli and broccoli seeds and sprouts 
[154]. Some of these studies are still at the 
very early stages and the mechanisms of ac-
tion in the human body are not yet well un-
derstood. The effects of these compounds 
on human health should be evaluated when 
more evidence is available.
18. Quantity of dose not stated.
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4.8. Probiotics and prebiotics
The gut flora or microbiota (i.e. all the micro-
organisms living in the human gut and the 
metabolites they generate) are essential for 
the maintenance of gut health. Changes in 
microbiota composition have been linked to 
inflammation and metabolic disorders such 
as inflammatory bowel disease, irritable bow-
el disease, diabetes, CVD, colorectal cancer, 
and frailty in old people [155]. Healthy adults 
have a relatively stable microbial composi-
tion in the gut. However, in older people, the 
composition tends to vary greatly between 
individuals and the microbiota diversity de-
clines with age [155]. Therefore, improving 
the microbial balance and composition in 
older people may help to reduce their risk 
for inflammation and metabolic diseases.
Probiotics and prebiotics have been pro-
posed to promote gut health, particularly in 
older people [155]. Probiotics are live micro- 
 organisms that, when administered in ade-
quate quantities, can confer a health benefit 
on the host [155]. Common types of probio-
tics include Lactobacilli and Bifidobacteria 
that are found in yoghurt and fermented 
milk products, as well as probiotic drinks 
and some fortified fruit juices [156]. Prebiot-
ics are non-digestible molecules that act as 
the substrate for the probiotic bacteria and 
selectively promote their growth and activ-
ity in the gut [155] [156]. Prebiotics can be 
found naturally in some vegetables, as well 
as in synthetic forms of non-digestible car-
bohydrates (e.g. oligosaccharides) [155] [156]. 
To date, there are few clinical studies that 
have investigated the effects of probiotics 
and prebiotics on the health of older people. 
However, some benefits have been recorded 
including improving bowel functions, e.g. 
reducing faecal transit time and relieving 
constipation [157], preventing antibiotic as-
sociated diarrhoea [156], increasing immune 
defence, and reducing inflammation, infec-
tions and allergies in older people [156].
4.9. Food-based evidence
  –The Mediterranean Diet
As discussed above, although micronutri-
ent supplementation appeared to hold great 
promise to benefit older adults in combating 
age-related physical and mental conditions, 
particularly if they are at risk of deficiency, 
the evidence to date has not yet conclu-
sively demonstrated such health-promoting 
effects. Therefore, it is crucial to obtain ad-
equate levels of nutrients through diet. The 
Mediterranean Diet (MD) (Table 4.4) is sug-
gested to have health benefits such as reduc-
ing the risk of developing type 2 diabetes, 
CVD, some neurodegenerative diseases and 
certain diet-related cancers [158]. A recent 
Cochrane review (2013) examined the effec-
tiveness of a Mediterranean dietary pattern 
for the primary prevention of CVD [159]. It 
was found that although the evidence was 
still limited to date, there were some favour-
able effects seen on cardiovascular risk fac-
tors. In particular, the more comprehensive 
interventions with more components of the 
MD produced more beneficial effects on 
lipid levels than those interventions with 
fewer MD components [159]. The Mediter-
ranean Diet Foundation produced a MD 
pyramid (Figure 4.2) that illustrates the main 
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Table 4.4. Description of the Mediterranean Diet.
Figure 4.2. The Mediterranean Diet pyramid.
Source: Bach-Faig et al. 2011 [158]
principles of the MD as well as taking into 
account healthy lifestyle behaviours; adapt-
ing to the various geographical, socio-eco-
nomic and cultural contexts of the Mediter-
ranean region [158].
The current evidence suggests that the 
health benefits of the MD may go beyond 
reducing CVD risks. A number of small 
cohort studies have suggested that adher-
ence to the MD increases longevity in sev-
The Mediterranean Diet includes high consumption of plant foods (e.g. fruit, vegetables, legumes, grains, nuts 
and seeds), complex carbohydrates such as bread and pasta, moderate consumption of fish, eggs, poultry and 
dairy products (e.g. cheese and yoghurt), low consumption of red meat and processed meat, low-to-moderate 
consumption of red wine with meals, and using olive oil as the main source of fats instead of animal fats. It cov-
ers a range of natural food sources high in key nutrients (e.g. protein, MUFAs and PUFAs, dietary fibre, antioxidant 
vitamins, minerals and polyphenols) and low in saturated and trans fats and added sugars [158] [160].
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eral European populations, for example in 
various Greek islands [161], Sicily [162], 
Spain [163], and even in non-Mediterranean 
populations such as UK [164] and Sweden 
[165] when the main MD principles were ap-
plied in the studies. Adherence to the MD 
is usually measured using variants of a food 
group scoring system to produce MD scores 
or indices; generally, the higher the score, 
the better the adherence to the MD. Large 
multi-country studies observed comparable 
positive findings. The EPIC-elderly (Euro-
pean Prospective Investigation into Cancer 
and Nutrition) prospective cohort study fol-
lowed over 74 000 older adults aged 60y+ in 
nine European countries (Denmark, France, 
Germany, Greece, Italy, the Netherlands, 
Spain, Sweden and the UK) and found that 
those who adhered to the MD had lower 
mortality rates [166]. For every 2-point in-
crease in the MD scores (on the scale of 0 
to 9), overall mortality was reduced by 8% 
[166]. A recently updated meta-analysis on 
the MD and health status including over 4 
million subjects also indicated that for each 
2-point increase in adherence score (scale 0 
to 18), there was an 8% reduction of overall 
mortality risk as well as a 10% reduction in 
CVD risk [167]. Similarly, the HALE pro-
ject (The Healthy Ageing: a Longitudinal 
study in Europe), which followed over 2 300 
healthy older men and women (aged 70 to 
90y) for ten years in eleven European coun-
tries, found that those adhering to the MD 
had a lower risk of all-cause mortality [168]. 
Furthermore, combining MD adherence 
with three other lifestyle behaviours–mod-
erate alcohol consumption, physical activity 
and not smoking, the rate of all-causes and 
cause-specific mortality (e.g. CVD and can-
cer) was reduced by more than 50% [168].
There is evidence to suggest that adherence 
to MD is also related to better cognition in 
older people. A meta-analysis assessed the 
association between the MD and cognitive 
decline (MCI and AD) from five prospective 
cohort studies with at least one year of fol-
low up. Participants in the high adherence 
group had a reduced risk (33% lower) in both 
MCI and AD, compared to those in the low 
adherence group [169]. Furthermore, high 
MD adherence scores reflected lower risk 
in developing MCI and AD among those 
with normal cognitive functions while those 
with existing MCI were less likely to pro-
gress to AD if they were strict MD adherers 
[169]. Another meta-analysis, which includ-
ed case-control studies, prospective cohorts 
and cross-sectional studies, investigated the 
association between MD and a number of 
brain-related conditions [170]. The pooled 
analysis showed that high adherence was 
strongly associated with reduced risk for 
stroke, depression, and cognitive impair-
ment (MCI, dementia and AD) [170].
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The EU is facing a future challenge of demo-
graphic change. It is important for all lev-
els and sectors of society to prepare for this 
challenge as early as possible and to embrace 
it as an opportunity, not only to prevent the 
development of a number of age-related 
problems that are known to affect current 
older people, but also to enable them to 
contribute to society as they grow older. To 
promote AHA, collective efforts and the in-
terplay of the six key determinants: (1) eco-
nomic determinants; (2) health and social 
services systems; (3) physical environment; 
(4) social environment; (5) cultural and per-
sonal determinants; and (6) behavioural de-
terminants are essential.
This report, addresses the contribution of 
nutrition in determining AHA. To increase 
healthy life years, it is essential to reduce 
and delay for as long as possible age-related 
functional decline and disability, to which 
undernutrition plays a large role. Given the 
importance of nutrient deficiency in disease 
development, we reviewed the current evi-
dence on the effect of key nutrient supple-
mentation in age-related disease prevention 
and treatment. At this stage, limited benefit 
is seen with supplementing single nutrients 
in older people to prevent or treat specific 
cognitive and functional impairments. It 
does not mean that supplementation is not 
 
 
 
 
 
 
 
effective; there are many possible explana-
tions for the lack of effects seen in the stud-
ies reviewed here. However, another alter-
native to ensure proper nutrition in older 
people is to maximise their intake of essen-
tial vitamins, minerals and bioactive com-
pounds from natural food sources. Indeed, 
the evidence so far on the Mediterranean Diet 
as a whole diet approach to promote health, 
increase longevity and reduce the risks of 
various age-related diseases supports this in 
a number of observational studies. It is pos-
sible that the natural micronutrients ingest-
ed from food can interact with each other 
and exhibit synergistic effects on health that 
are absent from supplementation of nutri-
ents in synthetic forms. Although there are 
other nutrition-related issues relevant to the 
older population (e.g. dietary risk factors in 
non-communicable diseases), the research 
described already indicates that there is a 
vast potential to focus further on promoting 
health through adequate intake from diet in 
this age group. The table below outlines sev-
eral potential areas for future research in this 
important field.
It is our hope that this report will raise aware-
ness of diet as a key contributor to healthy 
ageing, and that more attention will be giv-
en to diet and nutrition in policymaking to 
protect our older citizens.
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5.1. Further research opportunities
Table 5.1. A list of potential areas for future research.
• Given that most supplementation trials have not convincingly demonstrated high rates of success 
in age-related disease prevention and treatment, it is important that older people obtain adequate 
nutrients through diet. However, age-specific and up-to-date guidelines or recommendations 
specifically for older Europeans are not easy to find. A previous set of recommendations for older 
people from the WHO dates back from 2002 [5], and currently, there are no standard European 
recommendations/guidelines available for older individuals. As a first step, there is a need to have 
an understanding on how many EU Member States have recent dietary recommendations for older 
people, and whether such recommendations can be harmonised across Europe.
• Nutrition is one of the key lifestyle determinants of AHA, along with physical activity, smoking and 
alcohol consumption patterns. It does not act on ageing independently. In this report, we estab-
lished that age-related functional declines are causes as well as consequences of undernutrition. 
However, there are also wider AHA determinants such as social, economic and environmental 
aspects that can influence how well older people eat as well as age. An important area of research 
is the interrelationships of such factors on dietary behaviour and how they can ensure older 
people eat better. For example, social contact, health literacy, use of technology, accessibility and 
availability of food, are some of the factors that deserve further research.
• In relation to this, to encourage self-care and responsibility to achieve AHA, translating scientific 
evidence into key and simple public health messages that can be easily understood by the older 
population, such as drinking fluids regularly to prevent dehydration; eating adequate fruit and 
vegetables per day (e.g. 5-a-day); and being physically active, are very important. Future research 
should also focus on identifying the most effective strategies to promote these public health 
messages to the older population.
• The evidence base focuses on the current older population; however, it is not known whether 
observations and projections at present are applicable to the older population in the future. 
For example, the proportion of the current older population that was overweight or obese during 
their childhood or adulthood was very low. Therefore, the current observations on disease trends 
and rates are most likely to be based on individuals who are normal weight. With the current 
obesity epidemic, it is unknown whether obese children and young adults will age the same way 
as the current older population. It is therefore important to have pregnancy and birth cohorts to 
study ageing from the life-course perspective to observe how people age according to different 
biological as well as lifestyle attributes.
• With the aim to extend healthy life years and to encourage active and healthy ageing in many 
national public health agendas, it is important to identify the best measures or markers for 
AHA. Often, studies use mortality rate reduction or, in clinical studies, specific biomarkers such as 
telomere length as positive outcomes of ageing. However, there should also be a number of other 
validated, agreeable, cost-effective, and non-invasive measures and tools to quantify, for 
example, the quality of diet, fitness, and well-being in older people throughout different stages 
of ageing. Furthermore, it is important to recognise the diversity of old age. Research should 
distinguish different extents of ageing (e.g. the young-old, the old-old, and the very old).
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About the Partnership
The European Innovation Partnership on 
Active and Healthy Ageing (hereafter re-
ferred as the Partnership or EIP on AHA) 
is one of the European Commission’s an-
swers, within the framework of Europe 2020 
Strategy, to the demographic challenges that 
Europe is facing. The Partnership aims to 
improve the quality of life of older people 
and enable them to stay active for longer. It 
pursuits a triple win for Europe: a better life, 
with active ageing and independent living, 
for older people; the sustainability of social 
and health care systems and enhanced com-
petitiveness of European industry through 
new markets and business expansion.
The Partnership is a new stakeholder-driv-
en approach to research and innovation. It 
pools available resources and expertise by 
bringing together committed and motivated 
actors, from both the public and private sec-
tor that are active particularly in health pol-
icy at European, national and regional level.
The work is structured in three pillars reflect-
ing the ‘life stages’ of the older individual 
in relation to care processes: A) prevention, 
screening and early diagnosis; B) care and 
cure and C) active ageing and independent 
living. There are three ways that stakeholders 
 
 
 
 
contribute to the Partnership: the Reference 
Sites, the Action Groups and the Marketplace; 
to which the European Commission (EC) 
provides general guidance and support to 
the coordination of efforts.
One of the Partnership’s key achievements 
has been the mobilisation of stakeholders 
across Europe. Today, over 3 000 organisa-
tions, representing all EU Members States 
from different regions, are engaged in the 
implementation of individual voluntary 
commitments, under the banner of the EIP 
on AHA. The partners estimated to impact 
with their actions 30 million EU citizens 
and 2 million patients across Europe.
About Nutrition within the Partnership
 
Within the Partnership, a specific A3 Action 
Group (AG) on Prevention of Frailty19 is cur-
rently implementing a common action plan. 
Partners have committed to implement 
innovative solutions to better understand 
the underlying factors of frailty, to explore 
the association between frailty and adverse 
health outcomes in older people and to bet-
ter prevent and manage the frailty syndrome 
and its consequences.
19. The Action Group (AG) on ‘implementing integrated pro-
grammes for prevention, early diagnosis and management of 
functional decline, both physical and cognitive, in older people’ 
started work in June 2012. The AG is normally referred to as Preven-
tion of Frailty. 160 partners expressing a total of 131 commitments 
are working together in this multidisciplinary Action Group.
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Part of their objectives and activities address 
the challenges regarding nutritional care 
for older people (including hydration and 
promoting physical activity) in social and 
healthcare settings.
There seems to be a closed association be-
tween frailty and the nutrition status in old-
er people. Malnutrition in particular can 
increase the age-associated loss of muscle 
and strength and therefore play a role in 
the development of sarcopenia and physi-
cal impairment. Hydration status is also of 
particular importance in older people.
Moreover, given that the causes and conse-
quences of malnutrition fall across multi-
ple policy spheres (e.g. no single health pro-
fessional is accountable for malnutrition), 
concerted action is needed, as well as co-
ordination amongst different stakeholders.
What the AG on frailty is working on:
Building on already known aspects, the frail-
ty group’s current work provides examples of 
good practices of interventions and research 
in different settings and circumstances. 
Some examples of their work are presented 
in Table 1. They refer to the follow ing areas: 
screening for undernutrition; delivering in - 
formation and guidance to the general 
population, patients and care-givers to im-
prove their food intake and food habits; 
dietary interventions to counteract inflam-
matory status and contribute to a better 
understanding of nutritional needs in older 
people; research in the fields of biomarkers, 
functional food and dietary supplements; 
analyse the association between malnutri-
tion, muscle strength and frailty; creating 
linkages between the healthcare system and 
the community; screening programmes to 
identify food habits for disease prevention; 
elucidating the molecular mechanisms by 
which natural products retard the onset of 
frailty and functional decline; and creating 
and marketing appropriate foods or diet 
supplements to reduce frailty and maintain 
sensory perception.
More information on the Action Group and 
the Good practices is available at:
https://webgate.ec.europa.eu/eipaha/action-
group/index/a3
https://webgate.ec.europa.eu/eipaha/library 
/index/show/id/727
The added value of A3 AG
Although it is not always easy to disentangle 
the specific impact of the Action Group it-
self, it is important that all EU, national and 
regional initiatives move in the same direc-
tion and build up critical mass in the most 
important areas; frailty and nutrition being 
one of them.
The collection of good practices and the 
work implemented by the Partnership are 
contributing to: make health and nutrition 
national and EU priority; raise awareness 
of nutrition for health; implement screen-
ing for malnutrition; implement targeted 
interventions; get recognition of the role of 
hydration and supplements; and the role of 
technology and screening.
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The EC is prepared to support the transfer 
and scaling up of successful initiatives (such 
as the Good practices of the Action group 
partners) to other regions or sectors to help 
transform the good practices into regular 
activities that will end up improving the nu-
tritional status and healthy diet of the Euro-
pean population.
The EC welcomes collaboration with stake-
holders active in the field of active and 
healthy ageing in general as well as in spe-
cific related domains (e.g. nutrition) to en-
hance coordination of resources and reduce 
duplication of efforts.
Table 1. Examples of commitments and good practices in nutrition.
Country Organisation Example Content
Belgium Flanders region A gastrological
approach to
malnutrition
A gastrological practice-based and an evidence-
informed nursing approach–resulting in a mutual and 
customised set of interventions focused on the resident, 
his/her individual needs and wishes on food, the ward 
and the institution has a positively influence on the seri-
ousness and the frequency of malnutrition in the elderly.
Also an intervention in innovative homecare delivery 
to prevent undernutrition, in Bruges for 600 elderly at 
home. The interventions consist of a learning pro-
gramme, a systematic risk screening/monitoring, a 
hierarchy of actions starting with normal food driven 
by a gastroteam and good communication between the 
different actors involved in the nutritional care.
Belgium European Nutrition 
for Health Alliance 
(ENHA)
Provides routine nutritional screening and monitoring of 
undernutrition among persons aged 75 years or older.
Italy Campania region Food Against 
Frailty
Creates and markets appropriate foods or diet supple-
ments designed to reduce frailty in older people and to 
maintain sensory perception. Currently collaborating 
with industries. They are focused on the administration 
of vitamin D supplement through the diet, with oil, to 
improve prevention of osteoporosis, at the same time 
reducing osteoporotic fractures.
Portugal Bioactive Natural 
Food Ingredients 
for aging-people 
functional diet
They search for molecular structures present in natural 
matrices (including food industry residues) that could 
be active in age-related diseases, namely with impact in 
mental and cardiovascular health and diabetes. Differ-
ent biomarkers for age-related diseases are studied in 
order to gain a better understanding of the impact that 
natural food/ingredients have in an aging-person’s diet.
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Table 1. (cont.)
Country Organisation Example Content
Spain CSIC Healthy ageing 
with innovative 
functional foods/
leads for  
degenerative 
and metabolic 
diseases
Implementation of a project to develop functional foods 
that could be incorporated in the normal diet of the 
elderly to target specific needs, leading to improved 
quality of life. Through regional, governmental and 
private industry collaboration, they have developed a 
technology that allows conducting caramelisation of 
food carbohydrates under conditions that favour the 
formation of prebiotic oligosaccharides and incorporate 
them in the diet in a ‘natural’ manner (caramel is a 
common ingredient in the food industry with the GRAS–
’generally recognised as safe’ label). The technology has 
been licensed and is undergoing the scale up process.
UK Aston Ageing 
Centre
Baseline nutritional 
status, metabolic 
phenotype and 
interventions to 
improve function
Obesity has previously been shown to reduce lifespan 
by approximately ten years and to enhance the ageing 
process. Little is known as to why this happens, however, 
altered metabolism and storage of macro- and micro-
nutrients is postulated to play an important role. A 
cohort of healthy volunteers and type 2 diabetic / obese 
subjects of varying age have their body fat analysed 
and a sample of blood will be taken for phenotyping.  
It will establish normative population data and explore 
the effects of interventions that modulate lipid profiles 
on oxidative damage markers.
UK Northern Ireland Malnutrition 
screening and 
guidance for their 
use for the pre-
vention of frailty
Improve the quality of nutritional care of adults in 
Northern Ireland receiving health and social care, 
through the prevention, identification and management 
of malnutrition in all health and social care settings. 
They are promoting systematic, routine screening for 
pre-frailty stages in at risk patients and older people.
Relevant templates for malnutrition screening guiding 
principles to support person-centred care planning in 
relation to nutritional screening have been developed. 
Recommendations on how to raise awareness among 
practitioners of the screening tools available for use are 
available.
The 
Netherlands
Hanze University Currently developing an application for self-assessment 
of malnutrition risk and the monitoring of diet and 
physical activity.
Spain ISC III Madrid Non-Invasive 
Neurofunctional 
Evaluation
A project currently developed based on dietary interven-
tions with nutritional supplements that could prevent or 
delay the development of age-related hearing loss. It 
involves the industry creation of new nutritional prod-
ucts and it studies the impact of malnutrition on hearing 
in older people in the general population with animal 
models.
Europe Direct is a service to help you find answers to your questions about the European Union
Freephone number (*): 00 800 6 7 8 9 10 11
(*) Certain mobile telephone operators do not allow access to 00 800 numbers or these calls may be billed.
A great deal of additional information on the European Union is available on the Internet.
It can be accessed through the Europa server http://europa.eu/.
How to obtain EU publications
Our priced publications are available from EU Bookshop (http://bookshop.europa.eu),
where you can place an order with the sales agent of your choice.
The Publications Office has a worldwide network of sales agents.
You can obtain their contact details by sending a fax to (352) 29 29-42758.
European Commission
EUR 26666 EN – Joint Research Centre – Institute for Health and Consumer Protection
Title: The Role of Nutrition in Active and Healthy Ageing
Author(s): Tsz Ning Mak, Sandra Caldeira
Luxembourg: Publications Office of the European Union
2014 – 54 pp. – 21.0 x 29.7 cm
EUR – Scientific and Technical Research series – ISSN 1831-9424
ISBN 97978-92-79-38435-6
doi:10.2788/83557
Abstract
Europe is facing an ageing population. Life expectancy is at its highest and many European populations are experiencing 
major demographic changes and transition towards a much older population structure. However, despite living longer, many 
people suffer ill-health or disability in the last 15 to 20 years of life. To encourage active and healthy ageing and to help 
increase healthy life expectancy, the European Commission has launched the European Innovation Partnership on Active 
and Healthy Ageing (the Partnership), which aims to add an average of two healthy life years in Europe by 2020.
This report aims to support the Partnership and to review the contribution of diet and nutrition in increasing healthy life 
years and promoting active and healthy ageing (AHA). The report gives a description of the main determinants of AHA 
including economic, social and behavioural factors and how they may relate to diet. It focusses on the issue of undernutri-
tion in older people–both a cause and consequence of functional decline. Given the importance of undernutrition and that 
micronutrient deficiency is a common problem in older adults, this report summarises the evidence regarding micronutri-
ent supplementations in the prevention and treatment of age-related diseases and conditions. At this stage, the current 
evidence seems insufficient to support the use of vitamin and mineral supplementation to prevent or treat specific cogni-
tive or functional impairments in older people, although it does not imply that supplements are not effective. As it stands, 
another approach to ensure proper nutrition in older people is to maximise their intake of essential vitamins and minerals 
from natural food sources. Indeed, evidence so far on the Mediterranean Diet supports this whole diet approach to promote 
health, increase longevity and reduce the risks of various age-related diseases in observational studies. A number of re-
search gaps are also highlighted in this report. Above all, there is a need to provide better guidance on diet and nutrition for 
older people and a set of age-specific, up-to-date dietary recommendations is essential to achieve this.
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